RCT of Methotrexate Added to Treatment As Usual in Schizophrenia
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
The aim of the this study is to evaluate the effectiveness of methotrexate added to treatment
as usual on positive and negative symptoms, cognitive and social functioning and quality of
life of patients suffering from schizophrenia.
Phase:
Phase 1
Details
Lead Sponsor:
Pakistan Institute of Learning and Living Pakistan Institute of Living and Learning
Collaborators:
Abbasi Shaheed Hospital Dow University of Health Sciences Institute of Behavioural Sciences, Karachi, Pakistan Karwan e Hayat, Karachi, Pakistan